Radioligands for PET studies of central 5-HT receptors and re-uptake sites — Current status
- 1 November 1995
- journal article
- review article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 22 (8) , 1011-1018
- https://doi.org/10.1016/0969-8051(95)02024-1
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brainLife Sciences, 1994
- [11C]WAY 100635: A radioligand for imaging 5-HT1A receptors with positron emission tomographyLife Sciences, 1994
- [11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with petLife Sciences, 1993
- Positron-emitting radioligands for studies in vivo-probes for human psychopharmacologyJournal of Psychopharmacology, 1993
- Synthesis of a 11C-labeled novel, quinuclidine based ligand for the 5-HT3 receptorInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1992
- Ligands and tracers for PET studies of the 5-HT system—current statusInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992
- Evaluation of S-[11C]citalopram as a radioligand for in vivo labelling of 5-hydroxytryptamine uptake sitesInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992
- Synthesis and biodistribution of a new radiotracer for in vivo labeling of serotonin uptake sites by PET, cis-N,N-[11C]dimethyl-3-(2′,4′-dichlorophenyl)-indanamine (cis-[11C]DDPI)International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992
- A Method for the In Vivo Investigation of the Serotonergic 5‐HT2 Receptors in the Human Cerebral Cortex Using Positron Emission Tomography and 18F‐Labeled SetoperoneJournal of Neurochemistry, 1990
- In Vivo Labeling of Serotonin Uptake Sites with [3H]ParoxetineJournal of Neurochemistry, 1989